Ali Can Sungur, Ö. Bayır, Gökhan Toptaş, Şevket Aksoy, Sevilay Karahan, Volkan Yücel, Emel Çadallı Tatar, G. Saylam, M. Korkmaz
{"title":"Retrospective Analysis of Laryngeal Cancer Patients in a Tertiary Referral Center","authors":"Ali Can Sungur, Ö. Bayır, Gökhan Toptaş, Şevket Aksoy, Sevilay Karahan, Volkan Yücel, Emel Çadallı Tatar, G. Saylam, M. Korkmaz","doi":"10.4274/tao.2024.2023-12-2","DOIUrl":null,"url":null,"abstract":"locoregional-free survival (LRFS), and factors affecting recurrence were analyzed. Results: We included 573 patients with a mean age of 60.1±9.8 years. Of the 573 patients, 94.2% (540) were men, 93.7% (537) were smokers, 40.1% had at least one comorbid disease, and 69.8% (400) presented with glottic LSCC. The five-year OS, DSS, DFS, and LRFS rates for all cases were 65.7%, 79.9%, 67%, and 74.7%, respectively. In early-stage LSCC treatment, the rates of OS (p=0.008), DFS (p=0.024) and LRFS (p=0.01) were statistically significantly higher in the endolaryngeal laser surgery (ELS) group compared with the radiotherapy (RT) group. In advanced-stage LSCC treatment, total laryngectomy had statistically significantly higher five-year DFS (p=0.003) and LRFS (p=0.002) rates compared to chemoradiotherapy. Conclusion: Our study showed that ELS provided higher rates of OS, DFS, and LRFS compared to RT in the treatment of early-stage LSCC. Recurrence was significantly higher in supraglottic tumors, advanced-stage tumors, and in patients with clinical N positivity.","PeriodicalId":44240,"journal":{"name":"Turkish Archives of Otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkish Archives of Otorhinolaryngology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/tao.2024.2023-12-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
locoregional-free survival (LRFS), and factors affecting recurrence were analyzed. Results: We included 573 patients with a mean age of 60.1±9.8 years. Of the 573 patients, 94.2% (540) were men, 93.7% (537) were smokers, 40.1% had at least one comorbid disease, and 69.8% (400) presented with glottic LSCC. The five-year OS, DSS, DFS, and LRFS rates for all cases were 65.7%, 79.9%, 67%, and 74.7%, respectively. In early-stage LSCC treatment, the rates of OS (p=0.008), DFS (p=0.024) and LRFS (p=0.01) were statistically significantly higher in the endolaryngeal laser surgery (ELS) group compared with the radiotherapy (RT) group. In advanced-stage LSCC treatment, total laryngectomy had statistically significantly higher five-year DFS (p=0.003) and LRFS (p=0.002) rates compared to chemoradiotherapy. Conclusion: Our study showed that ELS provided higher rates of OS, DFS, and LRFS compared to RT in the treatment of early-stage LSCC. Recurrence was significantly higher in supraglottic tumors, advanced-stage tumors, and in patients with clinical N positivity.
分析了无局部生存期(LRFS)和影响复发的因素。结果我们共纳入了573名患者,平均年龄为(60.1±9.8)岁。573例患者中,94.2%(540例)为男性,93.7%(537例)为吸烟者,40.1%至少患有一种合并症,69.8%(400例)为声门LSCC。所有病例的五年OS、DSS、DFS和LRFS率分别为65.7%、79.9%、67%和74.7%。在早期LSCC治疗中,喉内激光手术(ELS)组的OS率(P=0.008)、DFS率(P=0.024)和LRFS率(P=0.01)与放疗(RT)组相比有显著统计学差异。在晚期LSCC治疗中,与化疗放疗相比,全喉切除术的五年DFS(p=0.003)和LRFS(p=0.002)率明显更高。结论我们的研究表明,在治疗早期LSCC时,ELS的OS、DFS和LRFS率均高于RT。声门上肿瘤、晚期肿瘤和临床 N 阳性患者的复发率明显更高。